Clever Leaves Holdings Inc.
DelistedCIK 1819615fmd_099DSZ7XEXCVCSJ7GKGTGFGYNBManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Dec 31, 2023, 17 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Total revenues | 8 | 12 | 15 | 16 | 17 |
| Cost of revenue | 5 | 5 | 9 | 9 | 11 |
| Gross profit | 3 | 7 | 7 | 7 | 7 |
| Realized investment gains (losses) | 1 | 0 | 0 | 7 | (4) |
| Research and development | – | 1 | 2 | 2 | 1 |
| Selling, general and administrative | 38 | 31 | 42 | 26 | 20 |
| Total operating expenses | 40 | 36 | 64 | 54 | 22 |
| Operating income | (37) | (29) | (57) | (47) | (16) |
| Other non-operating income (expense) | 9 | (3) | (13) | 3 | (4) |
| Income before taxes | (46) | (26) | (45) | (44) | (20) |
| Income tax expense | 0 | 0 | 1 | (6) | 0 |
| Net income from continuing operations | (46) | (26) | (46) | (38) | (20) |
| Net income | (40) | (26) | (46) | (66) | (18) |
| Net income to common shareholders | – | (36) | (46) | (66) | (18) |